|
Hernández-Romero D, Marín F, Roldán V, Peñafiel P, Vilchez JA, Orenes-Piñero E, Giner JA, Valdés M, García-Alberola A. Comparative determination and monitoring of biomarkers of necrosis and myocardial remodeling between radiofrequency ablation and cryoablation. Pacing Clin Electrophysiol. 2013 Jan;36(1):31-6. doi: 10.1111/pace.12017. PubMed PMID: 23078110.
AÑO: 2013; IF: 1.25
|
|
Roldán V, Marín F, Fernández H, Manzano-Fernandez S, Gallego P, Valdés M, Vicente V, Lip GY. Predictive value of the HAS-BLED and ATRIA bleeding scores for the risk of serious bleeding in a "real-world" population with atrial fibrillation receiving anticoagulant therapy. Chest. 2013 Jan;143(1):179-84. PubMed PMID: 22722228.
AÑO: 2013; IF: 7.132
|
|
Vílchez JA, Roldán V, Manzano-Fernández S, Fernández H, Avilés-Plaza F, Martínez-Hernández P, Vicente V, Valdés M, Marín F, Lip GY. ?-Trace protein and prognosis in patients with atrial fibrillation receiving anticoagulation treatment. Chest. 2013 Nov;144(5):1564-70. doi: 10.1378/chest.13-0922. PubMed PMID: 23975142.
AÑO: 2013; IF: 7.132
|
|
Cerezo-Manchado JJ, Rosafalco M, Antón AI, Pérez-Andreu V, Garcia-Barberá N, Martinez AB, Corral J, Vicente V, González-Conejero R, Roldán V. Creating a genotype-based dosing algorithm for acenocoumarol steady dose. Thromb Haemost. 2013 Jan;109(1):146-53. doi: 10.1160/TH12-08-0631. PubMed PMID: 23196355.
AÑO: 2013; IF: 5.76
|
|
Gallego P, Roldan V, Marín F, Romera M, Valdés M, Vicente V, Lip GY. Cessation of oral anticoagulation in relation to mortality and the risk of thrombotic events in patients with atrial fibrillation. Thromb Haemost. 2013 Dec;110(6):1189-98. doi: 10.1160/TH13-07-0556. PubMed PMID: 24096615.
AÑO: 2013; IF: 5.76
|
23078110